Download Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Global Blood and Urine Collection Market: By Product Type, Application, End User and Region Forecast 2020-2031
Global Blood and Urine Collection Market: By Product Type, Application, End User and Region Forecast 2020-2031
Blood and urine collection Market size was valued at US$ 9,647.3 million in 2024 and is projected to reach US$ 15,593.1 million by 2031 grew at 7.3% from 2025-2031. Moreover, the USA Blood and urine collection Market is projected to grow significantly, reaching an estimated value of US$ 3,873.1 Million by 2031.
The market encompasses all products, tools, and solutions used for collecting and transporting blood and urine samples for clinical and laboratory analysis. This market includes vacuum blood collection systems, micro-collection devices, urine sample cups, transport bags, and associated accessories used across healthcare facilities, research laboratories, and home healthcare setups.
The market are marked by continuous growth as healthcare systems worldwide emphasize early diagnosis and disease prevention. The increasing burden of lifestyle diseases, coupled with the expansion of diagnostic laboratories and point-of-care testing services, fuels market demand. Innovations focused on improving sample integrity, minimizing contamination risks, and enhancing patient comfort are shaping product development. Furthermore, rising healthcare investments in emerging markets and the growing elderly population are expected to provide new growth opportunities for market players.
The global market size is inclusive of several Blood and urine collection companies such as Becton, Dickinson and Company (BD), Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Cardinal Health, Inc., Terumo Corporation, Saray Medical, FL Medical S.r.l., Nipro Medical Corporation, Medtronic plc, Smiths Medical (part of ICU Medical, Inc.)
Based on the Product type:
Based on product type, blood collection devices are anticipated to lead the market and hold the largest share. This dominance is primarily driven by the growing global demand for routine blood tests, which are essential for diagnosing a wide range of conditions, from chronic diseases such as diabetes and cardiovascular disorders to infectious diseases and cancer. Blood tests are considered a fundamental part of preventive healthcare, early detection, and treatment monitoring. The rise in lifestyle-related illnesses, coupled with an aging population requiring regular health assessments, further boosts demand for advanced blood collection products. Additionally, the growing preference for minimally invasive procedures and the increasing use of automated blood collection systems in hospitals and diagnostic labs contribute to this segment’s growth. Continuous innovation in safety-engineered blood collection devices, such as vacuum-based tubes and closed systems that minimize contamination risks, also strengthens market leadership. As healthcare infrastructures expand globally, blood collection devices remain indispensable to clinical diagnostics.
Based on the Application:
Based on application, diagnostics is anticipated to lead the market, holding the largest share. The dominance of the diagnostics segment is driven by the increasing global demand for laboratory tests used in the detection, monitoring, and management of various diseases. Blood and urine samples are fundamental for diagnosing chronic conditions such as diabetes, cardiovascular diseases, kidney disorders, and infectious diseases. The growing burden of these conditions worldwide has accelerated the need for efficient diagnostic services. In addition, rising awareness about preventive healthcare and routine checkups has further increased the volume of diagnostic testing across hospitals, diagnostic labs, and outpatient clinics. The expanding elderly population, who require regular diagnostic evaluations, also plays a significant role in driving this segment. Moreover, advancements in laboratory technologies and automation have led to faster and more accurate test results, reinforcing the importance of blood and urine collection devices in diagnostics. This growing demand solidifies diagnostics as the leading application in the market.
Based on the end user:
Based on the end user, hospitals and clinics are anticipated to lead the market and hold the largest market share. This dominance is attributed to the high patient footfall, the constant need for diagnostic procedures, and the diverse range of healthcare services provided by hospitals and clinics. Blood and urine collection are routine processes in hospitals for diagnosing illnesses, monitoring patient conditions, and pre-surgical evaluations. The growing prevalence of chronic diseases, such as diabetes and hypertension, has resulted in a consistent increase in patient visits to healthcare facilities for regular monitoring, further driving demand. Additionally, emergency care and inpatient departments require frequent and reliable sample collection for rapid diagnostics. Hospitals also benefit from advanced laboratory setups that support automated blood collection systems and ensure accurate testing. As healthcare spending increases globally and hospital infrastructure continues to expand, the segment remains the largest end-user, driven by comprehensive patient care and continuous diagnostic requirements.
Study Period
2025-2031Base Year
2024CAGR
7.3%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The growing incidence of infectious and chronic diseases worldwide is one of the major factors propelling the blood and urine collection industry. The need for blood and urine collection items is greatly increased by chronic ailments like diabetes, cardiovascular diseases, cancer, and renal disorders, which necessitate regular diagnostic testing and ongoing monitoring. The demand for effective specimen collecting methods has increased due to infectious diseases such as HIV, TB, seasonal influenza, and the recent global impact of COVID-19. Diagnostic tests utilising blood and urine samples are becoming crucial instruments in clinical decision-making as early detection and prevention gain priority in healthcare systems worldwide. Furthermore, national health policies and public health campaigns promoting routine checkups and preventive healthcare contribute to consistent demand. The increasing patient population requiring periodic tests places emphasis on the development of safe, easy-to-use, and reliable collection devices. Blood and urine samples are critical for determining disease biomarkers, monitoring treatment progress, and screening populations at risk. This continuous need, combined with expanding healthcare access in developing nations, ensures that the growth trajectory for the market remains strong and sustained.
The existence of strict regulatory standards controlling the development, approval, and commercialisation of specimen collection equipment and consumables is a major barrier to the blood and urine collection business. Regulatory agencies like the European Medicines Agency (EMA), the U.S. Food and Drug Administration (FDA), and other regional health authorities have strict safety and quality requirements that medical devices and diagnostic consumables must meet. Although these rules are necessary to guarantee patient safety and the precision of diagnostic findings, they may also provide significant difficulties for producers. Research, product validation, and compliance documentation require significant time and financial investment from businesses. The process of obtaining approvals is often lengthy and subject to changing guidelines, which can delay product launches and innovation cycles. Additionally, any deviation or non-compliance discovered post-market can result in costly recalls, legal actions, and reputational damage. Smaller players and startups may find it particularly difficult to navigate these regulatory hurdles, limiting market entry. As regulations continue to evolve, the cost and complexity of compliance may slow down market growth, especially in price-sensitive regions.
An emerging opportunity within the market lies in the rapid expansion of diagnostic infrastructure in developing and emerging economies. Countries in Asia-Pacific, Latin America, and parts of Africa are witnessing significant growth in healthcare investments, driven by government initiatives to enhance public health systems and increase healthcare access for underserved populations. These regions are experiencing a surge in the establishment of new diagnostic laboratories, hospitals, and clinics, along with the integration of advanced laboratory technologies. The rise of health insurance penetration, urbanization, and increased patient awareness regarding preventive health checkups further supports the demand for diagnostic testing. As diagnostic capacity expands, there is a proportional need for reliable, high-quality blood and urine collection devices to support accurate laboratory operations. Multinational companies are actively entering these markets through collaborations, joint ventures, and localized manufacturing facilities to tap into this opportunity. Moreover, international health programs focusing on disease surveillance and large-scale screening projects in these regions present long-term growth potential for market players, making emerging markets a key area of strategic focus.
A prominent trend shaping the market is the growing adoption of automation and closed-system collection devices. Healthcare facilities and laboratories are increasingly embracing automation to enhance accuracy, reduce manual handling errors, and improve operational efficiency. Automated blood collection systems and vacuum-based urine collection containers are gaining popularity due to their ability to ensure sterile conditions, reduce the risk of contamination, and improve patient comfort. These closed-system devices minimize healthcare workers' exposure to potentially infectious materials, aligning with strict safety protocols. In addition, automated sample collection solutions integrate seamlessly with laboratory information management systems (LIMS), enabling real-time data capture, sample tracking, and reporting. This trend is further driven by the need for faster turnaround times and the increasing volume of diagnostic testing in both hospital and outpatient settings. The continuous advancements in collection tube design, pre-analytical processing devices, and barcode-based identification also reflect the market's shift toward automation and digitization. Manufacturers are investing heavily in R&D to develop smart, user-friendly devices that align with laboratory automation systems, signaling a future where manual collection methods are increasingly replaced by more efficient automated solutions.
Largest Share of the Region:
North America holds the largest share in the market, driven by advanced healthcare infrastructure, high healthcare spending, and widespread adoption of diagnostic testing. The presence of leading manufacturers such as Becton, Dickinson and Company, Thermo Fisher Scientific, and Cardinal Health, along with a robust network of hospitals, diagnostic laboratories, and research facilities, strengthens the region’s dominance. The U.S. leads this growth with more than 7,000 diagnostic laboratories and a rapidly aging population requiring frequent health monitoring. Furthermore, the growing prevalence of chronic conditions — with around 133 million Americans suffering from at least one chronic disease — boosts routine blood and urine sample collection. The driver behind this largest share is also the emphasis on advanced technologies, including automated and closed-system blood collection devices, and digital integration with healthcare IT systems. The trend of precision medicine and home-based sample collection kits further supports market growth in this region, making North America a mature and innovation-driven market leader.
Fastest Growing/ Emerging Region:
The Asia-Pacific region is emerging as the fastest-growing market for blood and urine collection, growth is driven by increasing healthcare expenditure, expanding diagnostic laboratories, and government-backed public health initiatives in countries such as China, India, Japan, and South Korea. In India alone, the diagnostics sector is expected to reach USD 32 billion by 2030, presenting massive demand for collection devices. China, with its rapidly aging population and rising chronic disease burden over 114 million diabetes patients as of 2023 also contributes significantly to market expansion. Key drivers in this region include the rising awareness of preventive healthcare and large-scale disease screening programs. Trends such as the adoption of point-of-care diagnostics, mobile healthcare services, and the localization of manufacturing by global players are reshaping the landscape. Additionally, increased regulatory reforms and investments in laboratory automation are accelerating the adoption of advanced blood and urine collection devices, positioning Asia-Pacific as a highly promising region for future growth.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2024 |
US$ 9,647.3 million |
|
Market Size in 2031 |
US$ 15,593.1 million |
|
Market CAGR |
7.3% |
|
By Product Type |
|
|
By Application |
|
|
By End User |
|
|
By Region |
|
According to PBI Analyst, the growth driven by rising global healthcare demands. The market continues to benefit from the increasing prevalence of chronic diseases, such as diabetes, cardiovascular conditions, and kidney disorders, which require regular diagnostic testing. Analysts observe that blood collection devices dominate the market, supported by technological innovations in vacuum-based systems and safety-engineered products that minimize contamination risks and enhance patient comfort. Diagnostics remain the leading application, as routine health checkups and preventive screenings become more common across both developed and developing regions. Furthermore, hospitals and clinics are identified as the primary end users due to high patient volumes and continuous diagnostic needs. The Asia-Pacific region stands out as the fastest-emerging market, driven by growing healthcare investments, expanding laboratory networks, and government-led screening programs. A noticeable trend is the increasing adoption of automated and closed-system collection devices, reflecting healthcare providers’ focus on operational efficiency and accuracy.
Download Free Sample Report
Blood and urine collection market size was valued at US$ 9,647.3 million in 2024 and is projected to reach US$ 15,593.1 million by 2031 grew at 7.3%.
The increasing prevalence of chronic and infectious diseases continues to drive demand for blood and urine collection devices globally.
The market is witnessing a strong trend toward automation and the adoption of closed-system collection devices to enhance safety and efficiency.
Market research is segmented based on product type, application, end user and region.
In the Asia-Pacific region, rising healthcare investments and expanding diagnostic infrastructure are key drivers fueling rapid market growth.
| 1.Executive Summary |
| 2.Global Blood And Urine Collection Market Introduction |
| 2.1.Global Blood And Urine Collection Market - Taxonomy |
| 2.2.Global Blood And Urine Collection Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Application |
| 2.2.3.End User |
| 2.2.4.Region |
| 3.Global Blood And Urine Collection Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Blood And Urine Collection Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Blood And Urine Collection Market By Product Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Blood Collection Devices |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Urine Collection Devices |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6.Global Blood And Urine Collection Market By Application, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Diagnostics |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Therapeutics |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Research & Development |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Disease Screening |
| 6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7.Global Blood And Urine Collection Market By End User, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Hospitals & Clinics |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Diagnostic Laboratories |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Blood Banks |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Home Healthcare |
| 7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Others |
| 7.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.Global Blood And Urine Collection Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Blood And Urine Collection Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. Product Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Blood Collection Devices |
| 9.1.2.Urine Collection Devices |
| 9.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Diagnostics |
| 9.2.2.Therapeutics |
| 9.2.3.Research & Development |
| 9.2.4.Disease Screening |
| 9.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals & Clinics |
| 9.3.2.Diagnostic Laboratories |
| 9.3.3.Blood Banks |
| 9.3.4.Home Healthcare |
| 9.3.5.Others |
| 9.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Blood And Urine Collection Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Blood Collection Devices |
| 10.1.2.Urine Collection Devices |
| 10.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Diagnostics |
| 10.2.2.Therapeutics |
| 10.2.3.Research & Development |
| 10.2.4.Disease Screening |
| 10.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals & Clinics |
| 10.3.2.Diagnostic Laboratories |
| 10.3.3.Blood Banks |
| 10.3.4.Home Healthcare |
| 10.3.5.Others |
| 10.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 11.Asia Pacific (APAC) Blood And Urine Collection Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Blood Collection Devices |
| 11.1.2.Urine Collection Devices |
| 11.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Diagnostics |
| 11.2.2.Therapeutics |
| 11.2.3.Research & Development |
| 11.2.4.Disease Screening |
| 11.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals & Clinics |
| 11.3.2.Diagnostic Laboratories |
| 11.3.3.Blood Banks |
| 11.3.4.Home Healthcare |
| 11.3.5.Others |
| 11.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Blood And Urine Collection Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Blood Collection Devices |
| 12.1.2.Urine Collection Devices |
| 12.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Diagnostics |
| 12.2.2.Therapeutics |
| 12.2.3.Research & Development |
| 12.2.4.Disease Screening |
| 12.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals & Clinics |
| 12.3.2.Diagnostic Laboratories |
| 12.3.3.Blood Banks |
| 12.3.4.Home Healthcare |
| 12.3.5.Others |
| 12.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Blood And Urine Collection Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Blood Collection Devices |
| 13.1.2.Urine Collection Devices |
| 13.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Diagnostics |
| 13.2.2.Therapeutics |
| 13.2.3.Research & Development |
| 13.2.4.Disease Screening |
| 13.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals & Clinics |
| 13.3.2.Diagnostic Laboratories |
| 13.3.3.Blood Banks |
| 13.3.4.Home Healthcare |
| 13.3.5.Others |
| 13.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Grifols |
| 14.2.2.Quest Diagnostics |
| 14.2.3.Teleflex Incorporated |
| 14.2.4.Hollister Incorporated |
| 14.2.5.Amsino International Inc. |
| 14.2.6.Boston Scientific Corporation |
| 14.2.7.Braun Melsungen AG |
| 14.2.8.Medline Industries, Inc. |
| 14.2.9.Becton |
| 14.2.10.Dickinson and Company (BD) |
| 14.2.11.Wihuri Packaging Oy. |
| 14.2.12.Sarstedt AG Co.KG |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.